首页> 美国卫生研究院文献>OncoTargets and therapy >miR-195 is a key regulator of Raf1 in thyroid cancer
【2h】

miR-195 is a key regulator of Raf1 in thyroid cancer

机译:miR-195是Raf1在甲状腺癌中的关键调控因子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Proto-oncogene Raf1 serves as a part of the mitogen-activated protein kinases/extracellular signal-regulated kinase signal transduction pathway and regulates cell migration, apoptosis, and differentiation. Although a large number of studies have shown that Raf1 is overexpressed in various kinds of cancer, little is known about the association between Raf1 and miRNAs in thyroid carcinoma. This study proves that Raf1 is overexpressed in thyroid cancer, which has been confirmed by many other studies. Besides, we identify that Raf1 is a direct target of miR-15a/b, miR-16, and miR-195 by dual luciferase reporter assay. We also find that the expression of miR-195 is downregulated in 50 pairs of thyroid tumor tissues compared to the adjacent nontumor tissues, while there is no difference in the expression of miR-15a/b and miR-16 between the groups. Furthermore, exogenous overexpression of miR-195 significantly inhibits the protein expression of Raf1 and blocks the thyroid cancer cell proliferation. Our findings delineate a novel mechanism for the regulation of Raf1 in thyroid cancer, which may help to provide a new direction for the treatment of thyroid cancer.
机译:原癌基因Raf1是丝裂原激活的蛋白激酶/细胞外信号调节激酶信号转导途径的一部分,并调节细胞迁移,凋亡和分化。尽管大量研究表明,Raf1在各种类型的癌症中均过表达,但对于甲状腺癌中Raf1与miRNA之间的关联了解甚少。这项研究证明Raf1在甲状腺癌中过表达,许多其他研究也证实了这一点。此外,我们通过双重萤光素酶报告基因分析确定Raf1是miR-15a / b,miR-16和miR-195的直接靶标。我们还发现,与相邻的非肿瘤组织相比,在50对甲状腺肿瘤组织中miR-195的表达下调,而两组之间miR-15a / b和miR-16的表达没有差异。此外,miR-195的外源性过表达显着抑制Raf1的蛋白质表达,并阻止甲状腺癌细胞的增殖。我们的发现勾画出了一种调节Raf1在甲状腺癌中的新机制,这可能有助于为甲状腺癌的治疗提供新的方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号